Complementary immunofluorescence staining of tumor tissues revealed significant downregulation of the Ki-67 proliferation marker across treatment groups (Fig. 3L & Fig. S5), accompanied by enhanced CD4+ and CD8+ T cell infiltration (Fig. 3M and N). The gene discussed is CD8A; the disease is neoplasm.